Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 218

1.

Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review.

Scott IA, Pillans PI, Barras M, Morris C.

Ther Adv Drug Saf. 2018 Jul 12;9(9):559-573. doi: 10.1177/2042098618784809. eCollection 2018 Sep. Review.

2.

Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

O'Dwyer M, McCallion P, McCarron M, Henman M.

Ther Adv Drug Saf. 2018 Jun 20;9(9):535-557. doi: 10.1177/2042098618782785. eCollection 2018 Sep. Review.

3.

Shed-MEDS: pilot of a patient-centered deprescribing framework reduces medications in hospitalized older adults being transferred to inpatient postacute care.

Petersen AW, Shah AS, Simmons SF, Shotwell MS, Jacobsen JML, Myers AP, Mixon AS, Bell SP, Kripalani S, Schnelle JF, Vasilevskis EE.

Ther Adv Drug Saf. 2018 Jun 15;9(9):523-533. doi: 10.1177/2042098618781524. eCollection 2018 Sep.

4.

Identifying and assessing potential harm of medication errors and potentially unsafe medication practices in paediatric hospital settings: a field study.

Rishoej RM, Almarsdóttir AB, Thybo Christesen H, Hallas J, Juel Kjeldsen L.

Ther Adv Drug Saf. 2018 Jun 12;9(9):509-522. doi: 10.1177/2042098618781521. eCollection 2018 Sep.

5.

Effect of a voice recognition system on pediatric outpatient medication errors at a tertiary healthcare facility in Kenya.

Migowa AN, Macharia WM, Samia P, Tole J, Keter AK.

Ther Adv Drug Saf. 2018 Jun 20;9(9):499-508. doi: 10.1177/2042098618781520. eCollection 2018 Sep.

6.

Dofetilide-induced anorexia in an older adult.

Felipe JV, Fixen DR, Linnebur SA.

Ther Adv Drug Saf. 2018 Jul;9(7):367-372. doi: 10.1177/2042098618773987. Epub 2018 May 10.

7.

Does the 5-HT1A rs6295 polymorphism influence the safety and efficacy of citalopram therapy in the oldest old?

Scutt G, Overall A, Scott R, Patel B, Hachoumi L, Yeoman M, Wright J.

Ther Adv Drug Saf. 2018 Jul;9(7):355-366. doi: 10.1177/2042098618770620. Epub 2018 Apr 23.

8.

Qualitative exploration of practices to prevent medication errors in neonatal intensive care units: a focus group study.

Rishoej RM, Lai Nielsen H, Strzelec SM, Fritsdal Refer J, Allermann Beck S, Gramstrup HM, Thybo Christesen H, Juel Kjeldsen L, Hallas J, Almarsdóttir AB.

Ther Adv Drug Saf. 2018 Jul;9(7):343-353. doi: 10.1177/2042098618771541. Epub 2018 Apr 23.

9.

Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study.

Jabaley CS, Wolf FA, Lynde GC, O'Reilly-Shah VN.

Ther Adv Drug Saf. 2018 Jul;9(7):331-342. doi: 10.1177/2042098618769565. Epub 2018 Apr 18.

10.

Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia.

Farina N, Anderson C.

Ther Adv Drug Saf. 2018 Jun;9(6):323-329. doi: 10.1177/2042098618768725. Epub 2018 Apr 11.

11.

The willingness and attitude of patients towards self-administration of medication in hospital.

Vanwesemael T, Boussery K, van den Bemt P, Dilles T.

Ther Adv Drug Saf. 2018 Jun;9(6):309-321. doi: 10.1177/2042098618764536. Epub 2018 Mar 26.

12.

Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence.

Rochester MP, Kane AM, Linnebur SA, Fixen DR.

Ther Adv Drug Saf. 2018 Jun;9(6):297-308. doi: 10.1177/2042098618772979. Epub 2018 May 4. Review.

13.

Metformin treatment of type 2 diabetes mellitus in pregnancy: update on safety and efficacy.

Polasek TM, Doogue MP, Thynne TRJ.

Ther Adv Drug Saf. 2018 Jun;9(6):287-295. doi: 10.1177/2042098618769831. Epub 2018 Apr 25. Review.

14.

Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety.

Gonzalez-Porras JR, Bastida JM.

Ther Adv Drug Saf. 2018 Jun;9(6):263-285. doi: 10.1177/2042098618769587. Epub 2018 Apr 19. Review.

15.

The pale evidence for treatment of iron-deficiency anaemia in older people.

Soiza RL, Donaldson AIC, Myint PK.

Ther Adv Drug Saf. 2018 Jun;9(6):259-261. doi: 10.1177/2042098618769568. Epub 2018 Apr 11. No abstract available.

16.

Designing a novel antacid for sensitive populations.

Sharifi-Sistani A, Tafazoli A.

Ther Adv Drug Saf. 2018 May;9(5):257-258. doi: 10.1177/2042098618764771. Epub 2018 Mar 14. No abstract available.

17.

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

De Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, Fornaro M, Di Fabio F, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M.

Ther Adv Drug Saf. 2018 May;9(5):237-256. doi: 10.1177/2042098618756261. Epub 2018 Feb 6. Review.

18.

Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined.

Mill D, Dawson J, Johnson JL.

Ther Adv Drug Saf. 2018 May;9(5):227-235. doi: 10.1177/2042098617751498. Epub 2018 Jan 24. Review.

19.

Moxifloxacin-induced tinnitus in an older adult.

Onoh A, Linnebur SA, Fixen DR.

Ther Adv Drug Saf. 2018 Apr;9(4):219-221. doi: 10.1177/2042098618754483. Epub 2018 Feb 6.

20.

Trigger alerts associated with laboratory abnormalities on identifying potentially preventable adverse drug events in the intensive care unit and general ward.

Buckley MS, Rasmussen JR, Bikin DS, Richards EC, Berry AJ, Culver MA, Rivosecchi RM, Kane-Gill SL.

Ther Adv Drug Saf. 2018 Apr;9(4):207-217. doi: 10.1177/2042098618760995. Epub 2018 Mar 1.

Supplemental Content

Loading ...
Support Center